5-Amino-2-[(2-amino-3-carboxypropanoyl)oxyamino]pentanoic acid (BioDeep_00000185426)

   

human metabolite blood metabolite


代谢物信息卡片


5-amino-2-{[(2-amino-3-carboxypropanoyl)oxy]amino}pentanoic acid

化学式: C9H17N3O6 (263.1117302)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(CC(C(=O)O)NOC(=O)C(CC(=O)O)N)CN
InChI: InChI=1S/C9H17N3O6/c10-3-1-2-6(8(15)16)12-18-9(17)5(11)4-7(13)14/h5-6,12H,1-4,10-11H2,(H,13,14)(H,15,16)



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Claudia Isabel Blanco Vela, Jorge Luis Poo Ramírez. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Annals of hepatology. 2011 Jun; 10 Suppl 2(?):S55-9. doi: 10.1016/s1665-2681(19)31608-4. [PMID: 22228883]
  • José Luis Pérez Hernández, Fátima Higuera de la Tijera, Aurora Elizabeth Serralde-Zúñiga, Juan Miguel Abdo Francis. Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Annals of hepatology. 2011 Jun; 10 Suppl 2(?):S66-9. doi: 10.1016/s1665-2681(19)31610-2. [PMID: 22228885]
  • Gavin Wright, Lorette Noiret, Steven W M Olde Damink, Rajiv Jalan. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver international : official journal of the International Association for the Study of the Liver. 2011 Feb; 31(2):163-75. doi: 10.1111/j.1478-3231.2010.02302.x. [PMID: 20673233]
  • A G Evdokimova, A É Radzevich, A V Tomova, V V Evdokimov, E V Kovalenko, L V Zhukolenko. [Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 2011; 56(5-6):64-8. doi: NULL. [PMID: 22145233]
  • Suzanna Ndraha, Marcellus Simadibrata. Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy. Acta medica Indonesiana. 2010 Jul; 42(3):158-61. doi: NULL. [PMID: 20724770]
  • P Kowalski, M Bieniecki. Pharmacokinetics and bioavailability study of L-ornithine-L-aspartate in healthy volunteers--a comparative study of two oral formulations. Journal of pharmaceutical and biomedical analysis. 2006 Jun; 41(3):1061-4. doi: 10.1016/j.jpba.2006.01.049. [PMID: 16524681]
  • P Kowalski, M Bieniecki, I Oledzka, H Lamparczyk. Validated method for L-ornithine-L-aspartate analysis in human plasma by capillary electrophoresis. Biomedical chromatography : BMC. 2006 Feb; 20(2):185-94. doi: 10.1002/bmc.551. [PMID: 16078310]
  • M Maneesh, H Jayalekshmi. Effect of ascorbic acid, alpha-tocopherol, lecithin and L-ornithine-L-aspartate on ethanol induced hypoproteinemia and hyperlipidemia in rats. Indian journal of physiology and pharmacology. 2005 Oct; 49(4):422-6. doi: NULL. [PMID: 16579395]
  • M Romero Gómez, J D Bautista, L Grande, R M Ramos Guerrero, D Sánchez Muñoz. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects]. Gastroenterologia y hepatologia. 2004 Feb; 27 Suppl 1(?):40-8. doi: NULL. [PMID: 15195533]